

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 7.46004146 |
| 2 | multicellular organismal reproductive behavior (GO:0033057) | 6.73607506 |
| 3 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 6.20893093 |
| 4 | meiotic chromosome segregation (GO:0045132) | 5.75001960 |
| 5 | protein-chromophore linkage (GO:0018298) | 5.41281274 |
| 6 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 5.21691592 |
| 7 | relaxation of smooth muscle (GO:0044557) | 5.09130960 |
| 8 | DNA deamination (GO:0045006) | 4.90343930 |
| 9 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.82470049 |
| 10 | multi-organism reproductive behavior (GO:0044705) | 4.60801343 |
| 11 | reproductive behavior (GO:0019098) | 4.46279657 |
| 12 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.39827533 |
| 13 | indolalkylamine metabolic process (GO:0006586) | 4.22397054 |
| 14 | NLS-bearing protein import into nucleus (GO:0006607) | 4.21277859 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.11662768 |
| 16 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.08985937 |
| 17 | transmission of nerve impulse (GO:0019226) | 3.79897080 |
| 18 | L-methionine salvage (GO:0071267) | 3.70038958 |
| 19 | L-methionine biosynthetic process (GO:0071265) | 3.70038958 |
| 20 | amino acid salvage (GO:0043102) | 3.70038958 |
| 21 | kynurenine metabolic process (GO:0070189) | 3.69017625 |
| 22 | negative regulation of myotube differentiation (GO:0010832) | 3.66219978 |
| 23 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.66015466 |
| 24 | indole-containing compound catabolic process (GO:0042436) | 3.63233767 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 3.63233767 |
| 26 | tryptophan catabolic process (GO:0006569) | 3.63233767 |
| 27 | rRNA catabolic process (GO:0016075) | 3.61078311 |
| 28 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 3.60450649 |
| 29 | proline biosynthetic process (GO:0006561) | 3.58992166 |
| 30 | glomerular visceral epithelial cell development (GO:0072015) | 3.55425177 |
| 31 | long term synaptic depression (GO:0060292) | 3.48418480 |
| 32 | methionine biosynthetic process (GO:0009086) | 3.45318191 |
| 33 | viral entry into host cell (GO:0046718) | 3.43962873 |
| 34 | S-adenosylmethionine metabolic process (GO:0046500) | 3.40687030 |
| 35 | tachykinin receptor signaling pathway (GO:0007217) | 3.36111194 |
| 36 | regulation of DNA-templated transcription, initiation (GO:2000142) | 3.36030824 |
| 37 | synaptic transmission, dopaminergic (GO:0001963) | 3.32600058 |
| 38 | positive regulation of interleukin-2 production (GO:0032743) | 3.24761281 |
| 39 | respiratory chain complex IV assembly (GO:0008535) | 3.23699235 |
| 40 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.12400865 |
| 41 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.05509817 |
| 42 | fucose catabolic process (GO:0019317) | 3.03718179 |
| 43 | L-fucose metabolic process (GO:0042354) | 3.03718179 |
| 44 | L-fucose catabolic process (GO:0042355) | 3.03718179 |
| 45 | glomerular epithelial cell development (GO:0072310) | 3.03599662 |
| 46 | cytoplasmic microtubule organization (GO:0031122) | 3.03443159 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03336745 |
| 48 | response to host immune response (GO:0052572) | 3.03336745 |
| 49 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.98793474 |
| 50 | cardiolipin metabolic process (GO:0032048) | 2.97467896 |
| 51 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.96225814 |
| 52 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.94777469 |
| 53 | nephron tubule formation (GO:0072079) | 2.94293107 |
| 54 | nitric oxide mediated signal transduction (GO:0007263) | 2.93209417 |
| 55 | startle response (GO:0001964) | 2.92433159 |
| 56 | methionine metabolic process (GO:0006555) | 2.90824696 |
| 57 | chaperone-mediated protein transport (GO:0072321) | 2.89868273 |
| 58 | cytochrome complex assembly (GO:0017004) | 2.88762494 |
| 59 | deoxyribonucleotide catabolic process (GO:0009264) | 2.86863198 |
| 60 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84922837 |
| 61 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84922837 |
| 62 | termination of RNA polymerase III transcription (GO:0006386) | 2.84792311 |
| 63 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.84792311 |
| 64 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.84473485 |
| 65 | UMP metabolic process (GO:0046049) | 2.84473485 |
| 66 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.84473485 |
| 67 | UMP biosynthetic process (GO:0006222) | 2.84473485 |
| 68 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.83225759 |
| 69 | regulation of metalloenzyme activity (GO:0048552) | 2.82389258 |
| 70 | cytidine deamination (GO:0009972) | 2.77085701 |
| 71 | cytidine metabolic process (GO:0046087) | 2.77085701 |
| 72 | cytidine catabolic process (GO:0006216) | 2.77085701 |
| 73 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.73351075 |
| 74 | detection of light stimulus involved in visual perception (GO:0050908) | 2.73351075 |
| 75 | regulation of cGMP biosynthetic process (GO:0030826) | 2.72905778 |
| 76 | proline metabolic process (GO:0006560) | 2.70529480 |
| 77 | deoxyribose phosphate catabolic process (GO:0046386) | 2.69074572 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.67858338 |
| 79 | parental behavior (GO:0060746) | 2.67679185 |
| 80 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.66055854 |
| 81 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.64352222 |
| 82 | microtubule severing (GO:0051013) | 2.63365351 |
| 83 | platelet dense granule organization (GO:0060155) | 2.61052698 |
| 84 | succinate metabolic process (GO:0006105) | 2.60440045 |
| 85 | indole-containing compound metabolic process (GO:0042430) | 2.59910619 |
| 86 | hydrogen peroxide catabolic process (GO:0042744) | 2.57964657 |
| 87 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 2.57953871 |
| 88 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 2.57953871 |
| 89 | entry into host (GO:0044409) | 2.57953871 |
| 90 | entry into other organism involved in symbiotic interaction (GO:0051828) | 2.57953871 |
| 91 | movement in host environment (GO:0052126) | 2.57953871 |
| 92 | entry into host cell (GO:0030260) | 2.57953871 |
| 93 | maternal behavior (GO:0042711) | 2.56458001 |
| 94 | intestinal epithelial cell development (GO:0060576) | 2.56040134 |
| 95 | response to amphetamine (GO:0001975) | 2.54947844 |
| 96 | negative regulation of smooth muscle contraction (GO:0045986) | 2.54287555 |
| 97 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.53350594 |
| 98 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.53096334 |
| 99 | female mating behavior (GO:0060180) | 13.7770447 |
| 100 | regulation of female receptivity (GO:0045924) | 13.1466533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.24406992 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.69741755 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.42416546 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.34273609 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92426199 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.89455850 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.88512851 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.75434643 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.58864446 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.08004015 |
| 11 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 2.06348770 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.01861427 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.97400373 |
| 14 | P300_19829295_ChIP-Seq_ESCs_Human | 1.94426985 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89665810 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89638191 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 1.88972602 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88919997 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.82364181 |
| 20 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.75652566 |
| 21 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.73855854 |
| 22 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.60441175 |
| 23 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.60441175 |
| 24 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.59130040 |
| 25 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.53852844 |
| 26 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.52764692 |
| 27 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52764692 |
| 28 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.52047051 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46758458 |
| 30 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.45762177 |
| 31 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.45698248 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45591879 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42910692 |
| 34 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39868255 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38310474 |
| 36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.38160156 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38097773 |
| 38 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.34263029 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34129365 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31625911 |
| 41 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31309937 |
| 42 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.29705857 |
| 43 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.28877622 |
| 44 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28298309 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26399896 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26319012 |
| 47 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25522704 |
| 48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23544541 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23144138 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22894371 |
| 51 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22414828 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22073403 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.19135751 |
| 54 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19096415 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19087931 |
| 56 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17779605 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.17415956 |
| 58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15412310 |
| 59 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14827304 |
| 60 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14827304 |
| 61 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14264888 |
| 62 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13723196 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12018837 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11966775 |
| 65 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.11962568 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10719276 |
| 67 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06211971 |
| 68 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05726377 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04839171 |
| 70 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04534949 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03121418 |
| 72 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00862055 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99940774 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98011625 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97831610 |
| 76 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97644247 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97643114 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97012673 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96448285 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95667812 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95447757 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95447757 |
| 83 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.94847610 |
| 84 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94579866 |
| 85 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94319111 |
| 86 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94118080 |
| 87 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.93809719 |
| 88 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93149609 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93008435 |
| 90 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92999528 |
| 91 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92787028 |
| 92 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91985703 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90540481 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90360083 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90125371 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90087614 |
| 97 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88716503 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88317541 |
| 99 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.88056885 |
| 100 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.86875807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 6.42368041 |
| 2 | MP0003136_yellow_coat_color | 5.69212338 |
| 3 | MP0002163_abnormal_gland_morphology | 4.32642013 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.47675832 |
| 5 | MP0002132_abnormal_respiratory_system | 3.06013888 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.02128524 |
| 7 | MP0004885_abnormal_endolymph | 3.01657051 |
| 8 | MP0005187_abnormal_penis_morphology | 2.97223469 |
| 9 | MP0003195_calcinosis | 2.94444951 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 2.68596581 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 2.65330260 |
| 12 | MP0004381_abnormal_hair_follicle | 2.54683888 |
| 13 | MP0003045_fibrosis | 2.45988781 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34110893 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.27225508 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.22263766 |
| 17 | MP0003879_abnormal_hair_cell | 2.21814567 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.09938189 |
| 19 | MP0005410_abnormal_fertilization | 2.08182593 |
| 20 | MP0003646_muscle_fatigue | 2.05857390 |
| 21 | MP0008775_abnormal_heart_ventricle | 2.04369971 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.99013348 |
| 23 | MP0009697_abnormal_copulation | 1.95563521 |
| 24 | MP0002736_abnormal_nociception_after | 1.75531959 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.62054331 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.59358138 |
| 27 | MP0002102_abnormal_ear_morphology | 1.55991014 |
| 28 | MP0009046_muscle_twitch | 1.54968447 |
| 29 | MP0001485_abnormal_pinna_reflex | 1.54140270 |
| 30 | MP0008877_abnormal_DNA_methylation | 1.51878844 |
| 31 | MP0003866_abnormal_defecation | 1.50744121 |
| 32 | MP0000647_abnormal_sebaceous_gland | 1.50062781 |
| 33 | MP0002168_other_aberrant_phenotype | 1.49827455 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.39232144 |
| 35 | MP0000383_abnormal_hair_follicle | 1.39188272 |
| 36 | MP0000230_abnormal_systemic_arterial | 1.32091155 |
| 37 | MP0005395_other_phenotype | 1.27219954 |
| 38 | MP0008872_abnormal_physiological_respon | 1.26745059 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.24854113 |
| 40 | MP0003638_abnormal_response/metabolism_ | 1.23375190 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.22854466 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.22621413 |
| 43 | MP0003786_premature_aging | 1.19592274 |
| 44 | MP0005360_urolithiasis | 1.18923978 |
| 45 | MP0003718_maternal_effect | 1.16668178 |
| 46 | MP0002090_abnormal_vision | 1.16049227 |
| 47 | MP0000681_abnormal_thyroid_gland | 1.15300635 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.01444013 |
| 49 | MP0005671_abnormal_response_to | 0.90664160 |
| 50 | MP0000685_abnormal_immune_system | 0.89972366 |
| 51 | MP0006054_spinal_hemorrhage | 0.88613802 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 0.87246299 |
| 53 | MP0010094_abnormal_chromosome_stability | 0.84075789 |
| 54 | MP0001486_abnormal_startle_reflex | 0.83393828 |
| 55 | MP0004130_abnormal_muscle_cell | 0.82463607 |
| 56 | MP0001986_abnormal_taste_sensitivity | 0.82142781 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.81496910 |
| 58 | MP0003938_abnormal_ear_development | 0.80731132 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 0.80047966 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 0.78508498 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 0.78423192 |
| 62 | MP0005253_abnormal_eye_physiology | 0.74502958 |
| 63 | MP0001348_abnormal_lacrimal_gland | 0.73296417 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 0.71845045 |
| 65 | MP0002282_abnormal_trachea_morphology | 0.70538684 |
| 66 | MP0010678_abnormal_skin_adnexa | 0.69424651 |
| 67 | MP0003077_abnormal_cell_cycle | 0.67966734 |
| 68 | MP0003252_abnormal_bile_duct | 0.65817558 |
| 69 | MP0001346_abnormal_lacrimal_gland | 0.65366040 |
| 70 | MP0004085_abnormal_heartbeat | 0.64988365 |
| 71 | MP0009764_decreased_sensitivity_to | 0.64969247 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 0.64910812 |
| 73 | MP0004215_abnormal_myocardial_fiber | 0.64652337 |
| 74 | MP0002272_abnormal_nervous_system | 0.64629139 |
| 75 | MP0001963_abnormal_hearing_physiology | 0.62445881 |
| 76 | MP0009745_abnormal_behavioral_response | 0.62385925 |
| 77 | MP0001188_hyperpigmentation | 0.62045163 |
| 78 | MP0005310_abnormal_salivary_gland | 0.61746313 |
| 79 | MP0003119_abnormal_digestive_system | 0.61430457 |
| 80 | MP0008995_early_reproductive_senescence | 0.58800549 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.58017894 |
| 82 | MP0009763_increased_sensitivity_to | 0.57664407 |
| 83 | MP0001929_abnormal_gametogenesis | 0.56973432 |
| 84 | MP0002210_abnormal_sex_determination | 0.56768965 |
| 85 | MP0003724_increased_susceptibility_to | 0.56418322 |
| 86 | MP0001800_abnormal_humoral_immune | 0.55679213 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.55567529 |
| 88 | MP0005174_abnormal_tail_pigmentation | 0.55409061 |
| 89 | MP0002160_abnormal_reproductive_system | 0.55069610 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.52593642 |
| 91 | MP0001756_abnormal_urination | 0.52303390 |
| 92 | MP0000049_abnormal_middle_ear | 0.52180761 |
| 93 | MP0002557_abnormal_social/conspecific_i | 0.50763870 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.50499723 |
| 95 | MP0001835_abnormal_antigen_presentation | 0.49648844 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.47623002 |
| 97 | MP0010155_abnormal_intestine_physiology | 0.46802541 |
| 98 | MP0000653_abnormal_sex_gland | 0.46630848 |
| 99 | MP0002452_abnormal_antigen_presenting | 0.45869600 |
| 100 | MP0001984_abnormal_olfaction | 0.45064542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Concave nail (HP:0001598) | 4.84668934 |
| 2 | Premature skin wrinkling (HP:0100678) | 4.38138426 |
| 3 | Mesangial abnormality (HP:0001966) | 4.28495055 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.22878381 |
| 5 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.12608732 |
| 6 | Tubular atrophy (HP:0000092) | 4.05477888 |
| 7 | Neonatal respiratory distress (HP:0002643) | 3.81154023 |
| 8 | Hypoproteinemia (HP:0003075) | 3.80732105 |
| 9 | Hemiparesis (HP:0001269) | 3.69038925 |
| 10 | Short chin (HP:0000331) | 3.66385359 |
| 11 | Anhidrosis (HP:0000970) | 3.64047862 |
| 12 | Keratoconjunctivitis (HP:0001096) | 3.35381347 |
| 13 | Abnormality of macular pigmentation (HP:0008002) | 3.35165143 |
| 14 | Conical tooth (HP:0000698) | 3.26821922 |
| 15 | Attenuation of retinal blood vessels (HP:0007843) | 3.23136847 |
| 16 | True hermaphroditism (HP:0010459) | 3.22138388 |
| 17 | Increased connective tissue (HP:0009025) | 3.13812829 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.02029940 |
| 19 | Bile duct proliferation (HP:0001408) | 3.00779088 |
| 20 | Abnormal biliary tract physiology (HP:0012439) | 3.00779088 |
| 21 | Oligodontia (HP:0000677) | 3.00766955 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.97496485 |
| 23 | Palpitations (HP:0001962) | 2.86938140 |
| 24 | Conjunctival hamartoma (HP:0100780) | 2.81446993 |
| 25 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.78786539 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 2.74978914 |
| 27 | Pustule (HP:0200039) | 2.72693860 |
| 28 | Severe visual impairment (HP:0001141) | 2.68808843 |
| 29 | Pelvic girdle muscle weakness (HP:0003749) | 2.67442567 |
| 30 | 11 pairs of ribs (HP:0000878) | 2.63635430 |
| 31 | Abnormal sex determination (HP:0012244) | 2.63544218 |
| 32 | Sex reversal (HP:0012245) | 2.63544218 |
| 33 | Pheochromocytoma (HP:0002666) | 2.63257605 |
| 34 | Esophageal neoplasm (HP:0100751) | 2.60194570 |
| 35 | Neoplasm of head and neck (HP:0012288) | 2.60194570 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.60013971 |
| 37 | Hamartoma of the eye (HP:0010568) | 2.59468785 |
| 38 | Absent eyebrow (HP:0002223) | 2.59166293 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 2.52417620 |
| 40 | Type II lissencephaly (HP:0007260) | 2.48376312 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.47513729 |
| 42 | Pancreatic cysts (HP:0001737) | 2.40892872 |
| 43 | Erythroderma (HP:0001019) | 2.38882030 |
| 44 | Cerebral hemorrhage (HP:0001342) | 2.37578312 |
| 45 | Rimmed vacuoles (HP:0003805) | 2.34745696 |
| 46 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.26138235 |
| 47 | Type I diabetes mellitus (HP:0100651) | 2.25505806 |
| 48 | Sparse eyelashes (HP:0000653) | 2.23001544 |
| 49 | Brittle hair (HP:0002299) | 2.21312392 |
| 50 | Prostate neoplasm (HP:0100787) | 2.19400486 |
| 51 | Increased CSF lactate (HP:0002490) | 2.18757396 |
| 52 | Redundant skin (HP:0001582) | 2.17608473 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.13086568 |
| 54 | B lymphocytopenia (HP:0010976) | 2.11134133 |
| 55 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.09937203 |
| 56 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.09937203 |
| 57 | Hypoplasia of the fovea (HP:0007750) | 2.08084335 |
| 58 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.08084335 |
| 59 | Cerebellar dysplasia (HP:0007033) | 2.06228526 |
| 60 | Thyroid-stimulating hormone excess (HP:0002925) | 2.06025185 |
| 61 | Pigmentary retinal degeneration (HP:0001146) | 2.05532365 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.05120874 |
| 63 | Decreased central vision (HP:0007663) | 2.05071328 |
| 64 | Respiratory difficulties (HP:0002880) | 2.04413687 |
| 65 | Cerebral hypomyelination (HP:0006808) | 2.02471136 |
| 66 | Mitochondrial inheritance (HP:0001427) | 2.02132641 |
| 67 | Abnormal tarsal ossification (HP:0008369) | 2.01990759 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 1.97067115 |
| 69 | Hyperthyroidism (HP:0000836) | 1.96830167 |
| 70 | Ependymoma (HP:0002888) | 1.95255328 |
| 71 | Abolished electroretinogram (ERG) (HP:0000550) | 1.94804118 |
| 72 | Hypothermia (HP:0002045) | 1.94451900 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93984848 |
| 74 | Hepatic necrosis (HP:0002605) | 1.89038708 |
| 75 | Colon cancer (HP:0003003) | 1.88522017 |
| 76 | Acute encephalopathy (HP:0006846) | 1.87651940 |
| 77 | Progressive inability to walk (HP:0002505) | 1.87367515 |
| 78 | Hypoplastic iliac wings (HP:0002866) | 1.87124400 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86252685 |
| 80 | Abnormality of alanine metabolism (HP:0010916) | 1.86252685 |
| 81 | Hyperalaninemia (HP:0003348) | 1.86252685 |
| 82 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.85925963 |
| 83 | Tinnitus (HP:0000360) | 1.85866789 |
| 84 | Neoplasm of the adrenal gland (HP:0100631) | 1.84893517 |
| 85 | Dysphonia (HP:0001618) | 1.84143057 |
| 86 | Birth length less than 3rd percentile (HP:0003561) | 1.82341055 |
| 87 | Male pseudohermaphroditism (HP:0000037) | 1.81658660 |
| 88 | Spinal muscular atrophy (HP:0007269) | 1.80106607 |
| 89 | Eosinophilia (HP:0001880) | 1.74112326 |
| 90 | Genetic anticipation (HP:0003743) | 1.72676241 |
| 91 | Hypoplastic nipples (HP:0002557) | 1.72401038 |
| 92 | Cystic liver disease (HP:0006706) | 1.71556887 |
| 93 | Angiofibromas (HP:0010615) | 1.69042801 |
| 94 | Adenoma sebaceum (HP:0009720) | 1.69042801 |
| 95 | Abnormality of the prostate (HP:0008775) | 1.67553945 |
| 96 | Cone-rod dystrophy (HP:0000548) | 1.67492386 |
| 97 | Increased serum lactate (HP:0002151) | 1.67077451 |
| 98 | Congenital hip dislocation (HP:0001374) | 1.65943311 |
| 99 | Neoplasm of the rectum (HP:0100743) | 1.65842602 |
| 100 | Abnormality of male internal genitalia (HP:0000022) | 1.65602910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.53641988 |
| 2 | MST4 | 3.80401828 |
| 3 | VRK2 | 3.26677593 |
| 4 | BUB1 | 3.07073660 |
| 5 | NUAK1 | 2.74037685 |
| 6 | EIF2AK3 | 2.72147316 |
| 7 | ADRBK2 | 2.69935596 |
| 8 | TIE1 | 2.64041604 |
| 9 | MKNK2 | 2.56641219 |
| 10 | PLK2 | 2.56604608 |
| 11 | TAF1 | 2.32967130 |
| 12 | CDK12 | 2.27859614 |
| 13 | KIT | 2.21730468 |
| 14 | MAP4K2 | 2.13056678 |
| 15 | OXSR1 | 2.06335579 |
| 16 | STK39 | 1.96552754 |
| 17 | EIF2AK1 | 1.93524073 |
| 18 | TXK | 1.77265229 |
| 19 | PINK1 | 1.65479560 |
| 20 | DAPK2 | 1.65284981 |
| 21 | VRK1 | 1.59425572 |
| 22 | GRK1 | 1.58671916 |
| 23 | TEC | 1.58530014 |
| 24 | MKNK1 | 1.58421545 |
| 25 | TAOK3 | 1.50895644 |
| 26 | ERBB2 | 1.48222050 |
| 27 | NEK1 | 1.37030992 |
| 28 | TSSK6 | 1.35203836 |
| 29 | TLK1 | 1.32147737 |
| 30 | CSNK1A1L | 1.28730406 |
| 31 | CSNK1G3 | 1.26460013 |
| 32 | ZAK | 1.25212109 |
| 33 | WNK4 | 1.24373766 |
| 34 | BCR | 1.19248552 |
| 35 | EIF2AK2 | 1.15389784 |
| 36 | ITK | 1.13860627 |
| 37 | PLK3 | 1.13088148 |
| 38 | KDR | 1.11081189 |
| 39 | PAK3 | 1.11006790 |
| 40 | ACVR1B | 1.03024824 |
| 41 | GRK5 | 0.96672926 |
| 42 | CSNK1G2 | 0.94919819 |
| 43 | PIM2 | 0.94518733 |
| 44 | IKBKB | 0.93493773 |
| 45 | DAPK1 | 0.87444765 |
| 46 | SYK | 0.87272401 |
| 47 | CSNK1G1 | 0.84719843 |
| 48 | PIK3CA | 0.84564191 |
| 49 | PHKG2 | 0.82726392 |
| 50 | PHKG1 | 0.82726392 |
| 51 | BMPR1B | 0.82072098 |
| 52 | PRKCI | 0.80876767 |
| 53 | PLK1 | 0.77974184 |
| 54 | BCKDK | 0.77721920 |
| 55 | INSRR | 0.76497799 |
| 56 | DYRK2 | 0.74288376 |
| 57 | WNK3 | 0.73300243 |
| 58 | MAP2K7 | 0.71368865 |
| 59 | PLK4 | 0.71185539 |
| 60 | ADRBK1 | 0.68688473 |
| 61 | IRAK3 | 0.67664295 |
| 62 | BRSK1 | 0.66795150 |
| 63 | MAP3K4 | 0.66634476 |
| 64 | PRKCE | 0.64134578 |
| 65 | MAP2K6 | 0.62296142 |
| 66 | PTK2B | 0.61223134 |
| 67 | MAPKAPK5 | 0.59452525 |
| 68 | EGFR | 0.59001355 |
| 69 | AURKB | 0.56521029 |
| 70 | BTK | 0.52767643 |
| 71 | PIK3CG | 0.47474548 |
| 72 | MAP3K10 | 0.47042856 |
| 73 | MAP3K1 | 0.46581387 |
| 74 | CLK1 | 0.46246896 |
| 75 | NME1 | 0.45412879 |
| 76 | PDK2 | 0.44141681 |
| 77 | DAPK3 | 0.44043432 |
| 78 | CSNK2A1 | 0.43381851 |
| 79 | ARAF | 0.41523009 |
| 80 | PRKCG | 0.40820029 |
| 81 | MINK1 | 0.39277274 |
| 82 | STK38 | 0.38665065 |
| 83 | CSNK1A1 | 0.38488709 |
| 84 | CHUK | 0.38283815 |
| 85 | PRKAA2 | 0.37385434 |
| 86 | PRKCQ | 0.36590251 |
| 87 | CDC7 | 0.36468745 |
| 88 | SMG1 | 0.35795120 |
| 89 | LYN | 0.35726531 |
| 90 | ROCK1 | 0.34372483 |
| 91 | CAMK2D | 0.34331575 |
| 92 | PRKCB | 0.34265845 |
| 93 | ATM | 0.33187332 |
| 94 | STK4 | 0.32935540 |
| 95 | LCK | 0.32235071 |
| 96 | CAMK2A | 0.32196459 |
| 97 | RPS6KA5 | 0.31881806 |
| 98 | WNK1 | 0.31637004 |
| 99 | IKBKE | 0.28083544 |
| 100 | CDK14 | 0.27535652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.92242343 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.44407838 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.29086915 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.50645464 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.42459418 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.40033327 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.39820738 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.38337418 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.35807134 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.03835623 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.97428075 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.89706757 |
| 13 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.88000060 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80173505 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.77185186 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69427150 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.63632377 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.62863483 |
| 19 | Purine metabolism_Homo sapiens_hsa00230 | 1.58081578 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.49105111 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48557123 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44121402 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.41313160 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39633123 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36746774 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.36380760 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.34482380 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31500305 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.28264426 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.26507704 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.25956177 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.16917523 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.14183035 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.10925351 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07195636 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.06511666 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06372219 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03468936 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03200972 |
| 40 | Lysine degradation_Homo sapiens_hsa00310 | 1.02706026 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.02443741 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02090944 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01996402 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01550526 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98321335 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98140300 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95628311 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94864852 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.93409121 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91392684 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90651028 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.87146268 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84689214 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84682169 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84528201 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80917820 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78814276 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78070974 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77965168 |
| 60 | Nicotine addiction_Homo sapiens_hsa05033 | 0.76558421 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75728296 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74132485 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.74116619 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73386440 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73319988 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69420037 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68490403 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66216241 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65114655 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64604877 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63319244 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62619277 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 0.62203628 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.61316716 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60112104 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.59690995 |
| 77 | RNA transport_Homo sapiens_hsa03013 | 0.58583512 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58194453 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57969977 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56268240 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56230281 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56105978 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52939018 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.51416927 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50923936 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.48145340 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46548555 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46427467 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45463268 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44594965 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42623258 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41627015 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39946268 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38288525 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38002055 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37105943 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36441374 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.35183718 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35039828 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32777929 |

